Come up with a name for your new list and we'll add to it:
Biovation was acquired by
Merck KGaA on October 27, 2000.
Biovation focuses on proprietary technologies that eliminate immunogenicity in antibodies and other proteins in order to develop biotherapeutic drugs with a superior safety profile. Biovation's techno…